Screening effectiveness of immunotherapeutic drug combinations in genetically engineered mouse models of human-like B-cell malignancies
Senior Researcher | Principal Investigator Lymphoproliferative Syndromes Research Group
- Convocation: 2018-2021
- Start date: August 31, 2018
- End date: August 31, 2021
- Funder: Immunotherapy Centers of Research Excellence (imCORE™) Network (NAV4/2017).
- Nature of project: International
Need more information?
If you are interested in learning more about our research, please contact us